Dr. Greg Stewart
Greg is the Better Medicines Theme Program Manager of the Neuromedicines Discovery Centre and co-head of the Molecular and Translational Drug Discovery lab. Greg has worked at the Monash Institute of Pharmaceutical Sciences since 2013 in collaborative industry programs to drive translational impact in GPCR drug discovery.
Greg’s research program is in drug discovery for psychiatric disorders, focussing on the role of GPCRs in depression, schizophrenia, cognitive disorders and addiction. The lab is also home to the Servier Discovery Program, which includes neuro-immune projects at different stages of the preclinical development.